ArticleQuantitative imaging in medicine and surgery2026
7.0 Tesla MRI in fetal autopsy: a preliminary exploration of integrating image optimization with clinical practice in a multidisciplinary workflow.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fetal and neonatal autopsies are crucial for determining causes of death and guiding future pregnancies; however, due to cultural and personal factors, their clinical application rates are decreasing. Noninvasive postmortem magnetic resonance imaging (PMMRI) has emerged as an alternative to fetal and neonatal autopsies. Ultra-high-field 7.0 Tesla (7.0T) PMMRI provides near-microscopic spatial resolution, superior tissue contrast, and a high signal-to-noise ratio compared to lower-field magnetic resonance imaging (MRI). However, its broader clinical application is challenged by stringent specimen preservation requirements, complex scanning parameters, and a lack of standardized multidisciplinary workflows. Thus, this study aimed to establish a multidisciplinary protocol for 7.0T PMMRI in fetuses, optimize the technical parameters based on practical experience, and validate its diagnostic consistency with pathological autopsy findings. Methods: This single-center workflow-optimization study included 20 fetuses delivered by induced labor (mean gestational age 26.4 weeks). Of the 20 fetuses, 19 underwent final pathological autopsy, and 13 had previously undergone Results: The 7.0T PMMRI workflow was optimized across five key aspects: body selection and preparation, 7.0T MRI setup, personnel readiness, data processing, and multidisciplinary death review. To ensure image quality and minimize issues related to freezing, compression, and autolysis, strict postmortem pretreatments were established, including that imaging should be conducted within 24 hours at 4 ℃. Scanning protocols were optimized to a duration of 60-120 minutes through the selection of appropriate magnetic resonance (MR) coils and sequences [e.g., T2-weighted imaging spin-echo (T2WI-SE) and susceptibility-weighted imaging (SWI)]. The consistency analysis revealed excellent diagnostic agreement between 7.0T PMMRI and pathological autopsy (Cohen's kappa =0.872, P<0.001), a value significantly higher than that between Conclusions: Integrating 7.0T PMMRI into a structured multidisciplinary workflow via the PDCA cycle effectively improved standardization, operational efficiency, and image quality. High-resolution 7.0T PMMRI exhibited high diagnostic consistency with traditional autopsy, supporting its role as a valuable and reliable noninvasive alternative for fetal postmortem examinations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.